83167-59-3

Basic information

• Product Name: 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)-
• Synonyms: 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)-
• CAS NO: 83167-59-3
• Molecular Formula: C₂₂H₄₆O₃
• Molecular Weight: 358.6
• Mol File: 83167-59-3.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)-(83167-59-3)
• EPA Substance Registry System: 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)-(83167-59-3)

Safety Data

• Hazardous Substances Data: 83167-59-3(Hazardous Substances Data)

Usage

General Description

1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)- is a chemical compound that belongs to the family of alcohols and ethers. It is a mixture of 1-propanol (an alcohol) and 2-methoxy-3-(octadecyloxy) (an ether) that is arranged in a specific stereoisomeric configuration, denoted as (2S)-. 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)- is commonly used as a solvent and is known for its ability to dissolve a wide range of substances. It is also used in a variety of industrial applications, such as in the production of pharmaceuticals and cosmetics. Additionally, it has potential applications in the field of organic synthesis and as a reagent in chemical reactions. Overall, 1-Propanol, 2-methoxy-3-(octadecyloxy)-, (2S)- is a versatile chemical compound with numerous uses in different industries.

Upstream product

• 866784-45-4 (R)-1-((tert-butyldimethylsilyl)oxy)-3-(octadecyloxy)propan-2-ol 
• 80707-93-3 (S)-1-O-octadecyl-2-O-benzyl-glycerol 
• 1348886-83-8 C₂₉H₅₂O₄ 
• 150844-22-7 1,6-di-O-octadecyl-2,5-di-O-methyl-3,4-bis-O-(4-methoxybenzyl)-D-mannitol 
• 31081-59-1 1-octadecyl methanesulfonate 
• 38169-74-3 1-O-Octadecyl-3-O-trityl-sn-glycerin 
• 6129-13-1 batyl alcohol 
• 150283-40-2 1-O-octadecyl-2-O-methyl-3-O-trityl-sn-glycerol 
• 83167-58-2 3-O-Benzyl-2-O-methyl-1-O-octadecyl-sn-glycerin 
• 90126-20-8 1,6-di-O-octadecyl-2,5-di-O-methyl-D-mannitol 
• 83537-01-3 (-)-1-O-octadecyl-2-O-acetyl-sn-glycerol 
• 83526-56-1 (S)-1,2-Epoxy-3-(octadecyloxy)propan 
• 83526-51-6 3-O-Octadecyl-2-O-p-toluolsulfonyl-3-O-trityl-sn-glycerin 
• 6076-32-0 3-O-Octadecyl-1-O-trityl-sn-glycerin 

Downstream Products

• 65492-82-2 (+)-Edelfosine 
• 253440-96-9 Phosphoric acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4,6-tetrakis-benzyloxy-cyclohexyl ester 
• 290812-37-2 Carbonic acid (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4,6-tetrahydroxy-cyclohexyl ester 
• 444902-95-8 ((S)-Hydroxy-{(1R,2R,3S,4R,5R,6R)-2,3,4,6-tetrakis-benzyloxy-5-[benzyloxy-((R)-2-methoxy-3-octadecyloxy-propoxy)-phosphoryloxy]-cyclohexyl}-methyl)-phosphonic acid dibenzyl ester 
• 444902-96-9 ((R)-Hydroxy-{(1R,2R,3S,4R,5R,6R)-2,3,4,6-tetrakis-benzyloxy-5-[benzyloxy-((R)-2-methoxy-3-octadecyloxy-propoxy)-phosphoryloxy]-cyclohexyl}-methyl)-phosphonic acid dibenzyl ester 
• 498554-94-2 Phosphoric acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-cyclohexylmethoxy-cyclohexyl ester 
• 498554-93-1 Phosphoric acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-isobutoxy-cyclohexyl ester 
• 498554-92-0 Phosphoric acid benzyl ester (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-methoxy-cyclohexyl ester 
• 498555-01-4 Carbonic acid (R)-2-methoxy-3-octadecyloxy-propyl ester (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-methoxy-cyclohexyl ester 
• 701976-54-7 phosphoric acid 2-methoxy-3-octadecyloxy-propyl ester 2,3,4-trihydroxy-6-methoxy-cyclohexyl ester 

Relevant articles and documents

ANTIVIRAL COMPOUNDS

The present disclosure provides compounds for treating a variety of diseases, such as respiratory syncytial virus (RSV), HRV, hMPV, ebola, Zika, West Nile, Dengue, and HCV.

D and L etherlipid stereoisomers and liposomes

A liposome having a lipid bilayer, where the lipid bilayer includes either the L or D stereoisomer of an ether lipid or a non-equal mixture of both. Most preferably the liposome also comprises (a) an underivatized phosphatidylcholine; (b) a sterol; (c) about 5-20 mole % of a phosphatidylethanolamine linked to a dicarboxylic acid at the ethanolamine group of the phosphatidylethanolamine, and (d) greater than about 10 mole % to less than about 30 mole % of either the L or D stereoisomer of an ether lipid. The liposome may be used as an anti-cancer or anti-inflammatory agent.

Chiral PAF agonists: Synthesis, theoretical analysis of their stereoelectronic properties and structure activity relationships

A series of chiral PAF agonists were synthesized. Modifications at the PAF structure were undertaken as far as the C2 substituents and the onium head groups are concerned. In parallel, molecular modelling studies including a MOPAC geometry optimization and the analysis of the electrostatic potential were performed on the newly synthesized and on already known PAF agonists, in order to gain a better insight into the stereoelectronic features required for interaction with the PAF receptor.